China's Biotechnology Rise Challenges U.S. Drug Development Dominance

China's rapidly growing biotechnology industry, highlighted at an international oncology gathering, is raising concerns about the potential waning of U.S. dominance in drug development and clinical trials.

30 May, 04:00 — 30 May, 04:00

Post Share

Sources

Showing 1 of 1 sources

NYTMostly Factual1h ago

China’s Rise in Drug Development Looms Over U.S.

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.

By Rebecca Robbins and Gina Kolata

Read full article →

PERSPECTA

PERSPECTA

China's Biotechnology Rise Challenges U.S. Drug Development Dominance

Sources

China’s Rise in Drug Development Looms Over U.S.

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

Hungary Sees Massive Spending with Lack of Financial Control

Bulgarian Court Opens Path to Reveal Cost of State Security for Delyan Peevski

Greece Grapples with Non-Performing Loans and Housing Solutions

PERSPECTA